Have a feature idea you'd love to see implemented?
Let us know!
ALZN Alzamend Neuro Inc
Price (delayed)
$1.3
Market cap
$5.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$10.65
Enterprise value
$3.86M
Highlights
ALZN's debt has dropped by 100% since the previous quarter
ALZN's EPS has soared by 55% year-on-year and by 28% since the previous quarter
The quick ratio has decreased by 34% YoY
Key stats
What are the main financial stats of ALZN
Market
Valuations
Earnings
Shares outstanding
3.89M
Market cap
$5.06M
Enterprise value
$3.86M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$7.37M
EBITDA
-$7.32M
Free cash flow
-$6.12M
Per share
Balance sheet
Liquidity
EPS
-$10.65
Free cash flow per share
-$7.86
Book value per share
-$1.44
Revenue per share
$0
TBVPS
$2.15
Total assets
$1.67M
Total liabilities
$2.88M
Debt
$0
Equity
-$1.21M
Working capital
-$1.47M
Debt to equity
0
Current ratio
0.49
Quick ratio
0.41
Net debt/EBITDA
0.16
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-727.1%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALZN stock price
How has the Alzamend Neuro stock price performed over time
Intraday
-0.76%
1 week
-10.96%
1 month
-24.86%
1 year
-88.07%
YTD
-85.39%
QTD
-23.08%
Financial performance
How have Alzamend Neuro's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.37M
Net income
-$7.39M
Gross margin
N/A
Net margin
N/A
ALZN's operating income has surged by 52% year-on-year and by 26% since the previous quarter
ALZN's net income has soared by 52% year-on-year and by 26% since the previous quarter
Growth
What is Alzamend Neuro's growth rate over time
Valuation
What is Alzamend Neuro stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ALZN's EPS has soared by 55% year-on-year and by 28% since the previous quarter
ALZN's equity has surged by 53% since the previous quarter
Efficiency
How efficient is Alzamend Neuro business performance
ALZN's ROA is up by 8% from the previous quarter
Dividends
What is ALZN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALZN.
Financial health
How did Alzamend Neuro financials performed over time
Alzamend Neuro's total assets is 42% less than its total liabilities
Alzamend Neuro's total assets has soared by 164% from the previous quarter but it has decreased by 36% YoY
The current ratio has contracted by 44% YoY
ALZN's debt is 100% greater than its equity
ALZN's debt has dropped by 100% since the previous quarter
ALZN's debt to equity has surged by 100% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.